Another feather in ReeLabs's cap. An empirical trial using our cutting-edge, patented (US patent granted) technology to treat sizeable number of patients suffering from Critical Limb Ischemia and Diabetic Foot and salvage and heal their limbs that were on the verge of amputation, just got published in the prestigious American Journal of Stem Cells..